NOVA2 anticorps (Middle Region)
Aperçu rapide pour NOVA2 anticorps (Middle Region) (ABIN629943)
Antigène
Voir toutes NOVA2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- NOVA2 antibody was raised against the middle region of NOVA2
-
Purification
- Purified
-
Immunogène
- NOVA2 antibody was raised using the middle region of NOVA2 corresponding to a region with amino acids EPEQVHKAVSAIVQKVQEDPQSSSCLNISYANVAGPVANSNPTGSPYASP
-
-
-
-
Indications d'application
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
NOVA2 Blocking Peptide, (ABIN938017), is also available for use as a blocking control in assays to test for specificity of this NOVA2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NOVA2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NOVA2 (Neuro-Oncological Ventral Antigen 2 (NOVA2))
-
Autre désignation
- NOVA2
-
Sujet
- NOVA2 may regulate RNA splicing or metabolism in a specific subset of developing neurons. It binds single strand RNA.
-
Poids moléculaire
- 54 kDa (MW of target protein)
Antigène
-